Advances and challenges in the prevention and treatment of COVID-19

被引：14

作者：

Han, Yan-Jie ^{[1
,2
,3
]}

Ren, Zhi-Guang ^{[1
,2
]}

Li, Xin-Xin ^{[3
]}

Yan, Ji-Liang ^{[3
]}

Ma, Chun-Yan ^{[3
]}

Wu, Dong-Dong ^{[1
,2
,4
]}

Ji, Xin-Ying ^{[1
,2
]}

机构：

[1] Henan Univ, Sch Basic Med Sci, Kaifeng Key Lab Infect Dis & Biosafety, Kaifeng 475004, Henan, Peoples R China

[2] Henan Univ, Sch Basic Med Sci, Henan Int Joint Lab Nucl Prot Regulat, Kaifeng 475004, Henan, Peoples R China

[3] Kaifeng Cent Hosp, Clin Lab & Funct Lab, Kaifeng 475000, Henan, Peoples R China

[4] Henan Univ, Sch Stomatol, Kaifeng 475004, Henan, Peoples R China

来源：

INTERNATIONAL JOURNAL OF MEDICAL SCIENCES | 2020年 / 17卷 / 12期

基金：

中国国家自然科学基金;

关键词：

SARS-CoV-2; COVID-19; virological characteristics; clinical treatment; drugs; RESPIRATORY SYNDROME CORONAVIRUS; VITRO ANTIVIRAL ACTIVITY; FAVIPIRAVIR T-705; SARS-COV; MERS-COV; RIBAVIRIN; VIRUS; REPLICATION; ACE2; INHIBITORS;

D O I：

10.7150/ijms.47836

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Since the end of 2019, a new type of coronavirus pneumonia (COVID-19) caused by the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) has been spreading rapidly throughout the world. Previously, there were two outbreaks of severe coronavirus caused by different coronaviruses worldwide, namely Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) and the Middle East Respiratory Syndrome Coronavirus (MERS-CoV). This article introduced the origin, virological characteristics and epidemiological overview of SARS-CoV-2, reviewed the currently known drugs that may prevent and treat coronavirus, explained the characteristics of the new coronavirus and provided novel information for the prevention and treatment of COVID-19.

引用

页码：1803 / 1810

页数：8

共 50 条

[21] Updates on Hydroxychloroquine in Prevention and Treatment of COVID-19
Hennekens, Charles H.
Rane, Manas
Solano, Joshua
Alter, Scott
Johnson, Heather
Krishnaswamy, Shiv
Shih, Richard
Maki, Dennis
DeMets, David L.
AMERICAN JOURNAL OF MEDICINE, 2022, 135 (01): : 7 - 9
[22] Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19
Singh, Bhagteshwar
Ryan, Hannah
Kredo, Tamara
Chaplin, Marty
Fletcher, Tom
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2021, (02):
[23] Vitamin D in the prevention or treatment of COVID-19
Martineau, Adrian R.
PROCEEDINGS OF THE NUTRITION SOCIETY, 2023, 82 (02) : 200 - 207
[24] Monoclonal Antibodies for Prevention and Treatment of COVID-19
Marovich, Mary
Mascola, John R.
Cohen, Myron S.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 324 (02): : 131 - 132
[25] Neutralizing antibodies for the prevention and treatment of COVID-19
Du, Lanying
Yang, Yang
Zhang, Xiujuan
CELLULAR & MOLECULAR IMMUNOLOGY, 2021, 18 (10) : 2293 - 2306
[26] Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19
Singh, Bhagteshwar
Ryan, Hannah
Kredo, Tamara
Chaplin, Marty
Fletcher, Tom
EMERGENCIAS, 2022, 34 (04): : 305 - 307
[27] Lactoferrin for COVID-19 prevention, treatment, and recovery
Bolat, Ecem
Eker, Furkan
Kaplan, Merve
Duman, Hatice
Arslan, Aysenur
Saritas, Suemeyye
Sahutoglu, Arif Sercan
Karav, Sercan
FRONTIERS IN NUTRITION, 2022, 9
[28] Analysis of COVID-19 prevention and treatment in Taiwan
Chiu, Yu-Jen
Chiang, Jo-Hua
Fu, Chih-Wei
Hour, Mann-Jen
Ha, Hai-Anh
Kuo, Sheng-Chu
Lin, Jen-Jyh
Cheng, Ching-Chang
Tsai, Shih-Chang
Lo, Yu-Shiang
Juan, Yu-Ning
Cheng, Yih-Dih
Yang, Jai-Sing
Tsai, Fuu-Jen
BIOMEDICINE-TAIWAN, 2021, 11 (01): : 1 - 18
[29] IMPORTANCE OF PROBIOTICS IN THE PREVENTION AND TREATMENT OF COVID-19
Eslami, Majid
Abdolshahi, Anna
Emadi, Alireza
Yousefi, Bahman
JOURNAL OF MICROBIOLOGY BIOTECHNOLOGY AND FOOD SCIENCES, 2022, 12 (03):
[30] Neutralizing antibodies for the prevention and treatment of COVID-19
Lanying Du
Yang Yang
Xiujuan Zhang
Cellular & Molecular Immunology, 2021, 18 : 2293 - 2306

← 1 2 3 4 5 →